USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
The session took place in the presence of Union Ministers Hardeep Singh Puri and Gen V K Singh along with Anil Agarwal, Rajya Sabha Member of Parliament
The upcoming portfolio of respiratory products aims to provide effective solutions for a range of respiratory conditions
Expands robotics to 20+ specialities
Twelve hospitals across India will be part of the network which will support the trial in India
More than 5 lakh patients availed the benefit of queue-less OPD registration using this service
This action follows the recent acceptance of the Marketing Authorization Application (MAA) for Pfizer’s RSV vaccine candidate by the European Medicines Agency
Subscribe To Our Newsletter & Stay Updated